Daniel W. Chan
12Patents
4h-index
18Co-inventors
53Inventor score
Filing activity: Aug 5, 2003 → Sep 8, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7510842B2 | Biomarker for ovarian and endometrial cancer: hepcidin | Physics | 87 | Expired |
| US7605003B2 | Use of biomarkers for detecting ovarian cancer | Emerging Cross-Sectional Technologies | 31 | Expired |
| US7951529B2 | Biomarkers for breast cancer | Physics | 14 | Active |
| US8440409B2 | Protein C inhibitor as a biomarker for prostate cancer | Physics | 4 | Active |
| US8682591B2 | Biomarkers for ovarian cancer | Physics | 1 | Active |
| US9891224B2 | Biomarkers for aggressive prostate cancer | Physics | 0 | Active |
| US9816995B2 | Biomarker for ovarian cancer CTAP3-related proteins | Physics | 0 | Active |
| US11255857B2 | Biomarkers for ovarian cancer CTAP3-related proteins | Physics | 0 | Active |
| US9551703B2 | High precision quantitative assay composition and methods of use therefor | Physics | 0 | Active |
| US9594086B2 | Biomarkers for aggressive prostate cancer | Physics | 0 | Active |
| US8603734B2 | Biomarkers for prostate cancer | Emerging Cross-Sectional Technologies | 0 | Active |
| US12037647B2 | Compositions and methods for detecting pancreatic cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.